Overview Cardiol Therapeutics. (NASDAQ:CRDL,TSX:CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company’s lead small molecule drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the…
(TheNewswire) Company now gearing up and actively enhancing its supply chain of fully integrated electrolyzers with capacities up to…
For a long time, most of the world’s lithium was produced by an oligopoly of producers often referred to…
Investor Insight Horizon Minerals’ near-term cash-flow potential and its significant land package in the prolific Western Australian goldfields with…
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 3.38 points last week to close at 570.71. Statistics Canada released its…
Experts have long warned that global overreliance on China for the production and processing of rare earth elements (REEs)…
Blue Sky Uranium (TSXV:BSK,OTCQB:BKUCF) announced on Monday (June 17) that it is expanding its exploration portfolio by acquiring two…
Heritage Mining Ltd. (CSE: HML) (“Heritage ” or the “Company ”) is pleased to announce that it has closed…
(TheNewswire) Vancouver, BC, June 21, 2024 TheNewswire Silver North Resources Ltd. (TSX-V: SNAG, OTCQB: TARSF) ‘ Silver North ‘…